AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6147080
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Bucindolol and Hydrochlorothiazide
Trial: 29953055
Drug: Tonsilgon-N (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tonsilgon-N (25 droplets thrice daily for 30 days) combined with 10 sessions of lagune cleansing using Tonsillor apparatus for 30 days
Trial: 27238057
Drug: Idebenone (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idebenone (900 mg/day)
Trial: 24576440
Drug: Local application
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local application of dexamethasone 4 mg/1 mL on the inferior alveolar nerve during BSSO surgery
Trial: 20080545
Drug: Tailor-made notched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailor-made notched music treatment
Trial: 20080545
Drug: Placebo notched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo notched music treatment
Trial: 17490472
Drug: First-generation antipsychotic
RxNorm normalized name: benzethonium chloride / lidocaine hydrochloride Topical Gel [Tecnu First Aid]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First-generation antipsychotic medication
Trial: 17490472
Drug: Second-generation antipsychotic
RxNorm normalized name: regenerated cellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-generation antipsychotic medication
Trial: 12410072
Drug: Thrice-daily (TID)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrice-daily (TID) regimen of methylphenidate (MPH)
Trial: 1974206
Drug: epanolol 200
RxNorm normalized name: epanolol
DrugBank: Epanolol (DB13757)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: epanolol 200 mg daily for 7 days
Trial: 22304887
Drug: 8-day intensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-day intensive treatment for panic disorder (PDA)
Trial: 16091146
Drug: Apple Juice
RxNorm normalized name: apple juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apple Juice (AJ) 15 ml/kg twice daily
Trial: 16091146
Drug: White Grape
RxNorm normalized name: Herbal Essences White Grapefruit Shampoo
DrugBank: Wine grape (DB10634)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: White Grape Juice (WGJ) 15 ml/kg twice daily
Trial: 10702653
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg titrated to Losartan 50 mg/Hydrochlorothiazide (HCT) 12.5 mg (n = 11)
Trial: 10702653
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg titrated to 10 mg (n = 14)
Trial: 8590958
Drug: GHRH‐antagonist (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRH‐antagonist (100 micrograms/100 ml saline over 75 min) administered in the morning
Trial: 8590958
Drug: GHRH‐antagonist (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRH‐antagonist (100 micrograms/100 ml saline over 75 min) administered in the evening
Trial: 1717206
Drug: solution enriched
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: solution enriched with branched chain amino acid (45% BCAA)
Trial: 1717206
Drug: balanced amino
RxNorm normalized name: silk amino acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: balanced amino acid solution (24% BCAA)
Trial: 6184569
Drug: Verapamil (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (160 mg thrice daily)
Trial: 6184569
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg slow release twice daily)
Trial: 23841976
Drug: Kinesio Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kinesio Tape applied to hand and forearm for 6 days in combination with standard therapy
Trial: 21349365
Drug: Trivalent Inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent Inactivated Vaccine (TIV)
Trial: 21349365
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of TIV
Trial: 19307354
Drug: Intravenous cloxacillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cloxacillin for 6 weeks plus 2 weeks orally (p.o.)
Trial: 19307354
Drug: Oral rifampin‐cotrimoxazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rifampin‐cotrimoxazole for 8 weeks p.o.
Trial: 19307354
Drug: Oral rifampin‐cotrimoxazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rifampin‐cotrimoxazole
Trial: 17325405
Drug: Lay‐led self
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lay‐led self care support group (6‐weekly sessions to teach self care skills)
Trial: 15038927
Drug: Evidence-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based treatment
Trial: 15038927
Drug: Adjunctive therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive therapies and combination medications
Trial: 11351771
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro (LP) combined with insulin lispro protamine suspension (NPL)
Trial: 11351771
Drug: Regular human
RxNorm normalized name: insulin regular human recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular human insulin (HR) combined with human NPH insulin (NPH)
Trial: 9684796
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose TNFR:Fc (10 mg/m2 i.v., n = 6)
Trial: 9684796
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose TNFR:Fc (60 mg/m2 i.v., n = 6)
Trial: 7802318
Drug: Combined anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined anesthesia based on NLA agents and placebo (simulated transcerebral electropulse exposure), n = 14
Trial: 2657207
Drug: Chlorophyllypt (0.25%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorophyllypt (0.25% solution in physiological sodium chloride solution administered by intravenous drip)
Trial: 2657207
Drug: Traditional antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional antibiotic therapy
Trial: 2657207
Drug: Broad-action antibiotics
RxNorm normalized name: broad leaved paperbark pollen extract
DrugBank: Melaleuca quinquenervia pollen (DB10478)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broad-action antibiotics
Trial: 29432877
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D and probiotic co-supplementation (50,000 IU vitamin D every 2 weeks plus 8 × 10^9 CFU/g probiotic)
Trial: 27473162
Drug: Anterior approach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anterior approach ISB with 15 ml of ropivacaine 1%
Trial: 27473162
Drug: Posterior approach
RxNorm normalized name: posterior pituitary hormones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Posterior approach ISB with 15 ml of ropivacaine 1%
Trial: 20887495
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg daily of pyridoxine
Trial: 20887495
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg daily of pyridoxine
Trial: 15702341
Drug: Strength training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strength training (24-week program, twice per week, consisting of calf-rise and leg-press exercises at 75% of three-repetition maximum)
Trial: 2107994
Drug: Systemic antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic antibiotics (SA)
Trial: 30843263
Drug: Imipramine 50
RxNorm normalized name: trimipramine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine 50 mg
Trial: 30379634
Drug: Traditional Prolonged
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Prolonged Exposure Therapy
Trial: 23657721
Drug: Control (10-cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (10-cc syringe)
Trial: 22004306
Drug: 8-session facilitated
RxNorm normalized name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [SESSION SAVERS SUNSCREEN BROAD SPECTRUM SPF 30 WATER RESISTANT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-session facilitated group cognitive behavioral therapy-based intervention
Trial: 10052670
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (400 mcg)
Trial: 7973119
Drug: Methazolamide treatment
RxNorm normalized name: Methazolamide
DrugBank: Methazolamide (DB00703)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methazolamide treatment
Trial: 21564160
Drug: Terutroban 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terutroban 2.5 mg
Trial: 21564160
Drug: Terutroban 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terutroban 5 mg
Trial: 21564160
Drug: Terutroban 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terutroban 10 mg
Trial: 19232204
Drug: Non-fractionated Heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-fractionated Heparin (NFH)
Trial: 17348237
Drug: Zhong tong'an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zhong tong'an combined with dexamethasone tablets
Trial: 17348237
Drug: Dexamethasone tablets
RxNorm normalized name: Dexamethasone Tablets
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone tablets alone
Trial: 15087602
Drug: Placebo bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo bolus and infusion
Trial: 9172024
Drug: sublingual buprenorphine
RxNorm normalized name: buprenorphine Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual buprenorphine 0.2 mg
Trial: 9172024
Drug: oral controlled
RxNorm normalized name: Afeditab CR Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral controlled release morphine 10 mg
Trial: 9172024
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine (10 ml) wound infiltration
Trial: 7712621
Drug: Pentoxifylline (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (600 mg daily for 5 days) + Aspirin (150 mg daily)
Trial: 7712621
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + Aspirin (150 mg daily)
Trial: 3438581
Drug: Sustained theophylline
RxNorm normalized name: Theophylline
DrugBank: Theophylline (DB00277)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained theophylline administration
Trial: 26683453
Drug: Daily positive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily positive affect among nonstudents
Trial: 26683453
Drug: Daily negative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily negative affect among nonstudents
Trial: 26683453
Drug: Daily negative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily negative affect among college students
Trial: 15895316
Drug: High concentration
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High concentration arginine aspartate (5.7 g arginine and 8.7 g aspartate)
Trial: 15895316
Drug: Low concentration
RxNorm normalized name: Dianeal Low Calcium 1.5 Intraperitoneal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low concentration arginine aspartate (2.8 g arginine and 2.2 g aspartate)
Trial: 3169046
Drug: Calcium antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonists (Verapamil and Diltiazem)
Trial: 26795448
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy and supervised exercise (MTEX)
Trial: 24041131
Drug: Combined buprenorphine-naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined buprenorphine-naloxone and behavioral treatment
Trial: 22858452
Drug: Prednisolone at
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone at a dose of 2 mg/kg/day (first group: 40 attacks)
Trial: 22858452
Drug: Prednisolone at
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone at a dose of 0.5 mg/kg/day (second group: 46 attacks)
Trial: 22858452
Drug: Prednisolone at
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone at a dose of 0.5 mg/kg/day (second group)
Trial: 12003482
Drug: Braun Oral-B
RxNorm normalized name: bran Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Braun Oral-B Battery toothbrush (D4)
Trial: 16163912
Drug: Low-dose aprotinin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose aprotinin (Group 2)
Trial: 16163912
Drug: High-dose aprotinin
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose aprotinin (Group 3)
Trial: 10583311
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg 17beta-oestradiol daily
Trial: 8582471
Drug: Dexibuprofen 400
RxNorm normalized name: Dexibuprofen 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexibuprofen 400 mg tablet formulation
Trial: 8582471
Drug: Dexibuprofen 200,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexibuprofen 200, 400, and 600 mg
Trial: 8582471
Drug: Ibuprofen racemate
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen racemate 400, 800, and 1200 mg
Trial: 2118408
Drug: BCAA-enriched TPN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA-enriched TPN (0.56 g BCAA kg‐1 body-weight, 50.2% BCAA)
Trial: 2118408
Drug: Standard TPN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard TPN (0.18 g BCAA kg‐1 body-weight, 15.6% BCAA)
Trial: 29028762
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of morphine and midazolam
Trial: 29028762
Drug: Intermittent dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent dosing only
Trial: 27567239
Drug: Intravenous thrombolysis
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thrombolysis plus mechanical thrombectomy (IVTMT group)
Trial: 27567239
Drug: Intravenous thrombolysis
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thrombolysis alone (IVT group)
Trial: 20864406
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of imatinib treatment
Trial: 20864406
Drug: Interruption of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interruption of imatinib treatment
Trial: 15812075
Drug: Maintenance vinorelbine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance vinorelbine (25 mg/m²/week for 6 months)
Trial: 10759821
Drug: 5% 5‐FU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% 5‐FU in a PC vehicle (cream A)
Trial: 10759821
Drug: 5% 5‐FU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% 5‐FU in a petrolatum base (cream B)
Trial: 9322481
Drug: Chlorzoxazone (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorzoxazone (500 mg orally on the morning of surgery)
Trial: 9322481
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no chlorzoxazone administration)
Trial: 3781021
Drug: Low-dose bromocriptine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose bromocriptine (1.25 to 2.5 mg) at bedtime for the first 18 days of the cycle (Group A)
Trial: 3781021
Drug: Pyridoxine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridoxine (100 mg continuously) (Group B)
Trial: 20156908
Drug: Letrozole (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole (2.5 mg) plus Lapatinib (1,500 mg)
Trial: 20156908
Drug: Letrozole (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole (2.5 mg) plus Placebo
Trial: 18577934
Drug: Amitriptyline 50
RxNorm normalized name: amitriptyline 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 50 mg daily
Trial: 18577934
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of antidepressants with transcranial electrostimulation
Trial: 11450419
Drug: One-stage cylindrical
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-stage cylindrical screw implants with a synthetic bone substitute
Trial: 11450419
Drug: Hollow screw-type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hollow screw-type implants
Trial: 11450419
Drug: Solid screw-type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solid screw-type implants
Trial: 11450419
Drug: One-stage implant
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-stage implant osseointegration with synthetic graft material
Trial: 3043555
Drug: Ceruletide (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceruletide (0.8 micrograms/kg, intramuscular injections, once weekly for 4 weeks)
Trial: 3043555
Drug: Placebo (intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (intramuscular injections, once weekly for 4 weeks)
Trial: 8230622
Drug: Active antiarrhythmic
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active antiarrhythmic drug therapy (encainide, flecainide, moricizine)
Trial: 681543
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose marihuana
Trial: 681543
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose marihuana
Trial: 25572623
Drug: Perception of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perception of preceptors as excellent role models in tobacco treatment
Trial: 25572623
Drug: Observation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Observation of tobacco treatment
Trial: 23228172
Drug: Abiraterone acetate
RxNorm normalized name: ABIRATERONE ACETATE
DrugBank: Abiraterone (DB05812)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Abiraterone acetate (1000 mg) plus prednisone (5 mg twice daily)
Trial: 17132719
Drug: Full-dose cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose cyclophosphamide (3.3 g/m2)
Trial: 17132719
Drug: Half-dose cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-dose cyclophosphamide (1.65 g/m2)
Trial: 15529609
Drug: Diosmectite 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diosmectite 3 g b.i.d.
Trial: 15529609
Drug: Loperamide 2
RxNorm normalized name: loperamide 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide 2 mg b.i.d.
Trial: 11167469
Drug: Midazolam 0.025
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.025 mg x kg(‐1)
Trial: 11167469
Drug: Midazolam 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.05 mg x kg(‐1)
Trial: 9596231
Drug: General wards
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General wards treatment
Trial: 2073105
Drug: Cefprozil 15
RxNorm normalized name: Cefprozil
DrugBank: Cefprozil (DB01150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefprozil 15 mg/kg
Trial: 7811050
Drug: Cefprozil 20
RxNorm normalized name: Cefprozil
DrugBank: Cefprozil (DB01150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefprozil 20 mg/kg
Trial: 3293253
Drug: Laser therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser therapy combined with indomethacin at a daily dose of 75-100 mg
Trial: 31989965
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (massage and exercises)
Trial: 21112904
Drug: Combined aerobic
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined aerobic and strength training (twice a week for 20 weeks)
Trial: 19440326
Drug: Early ART
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early ART (initiated within 14 days of starting acute OI treatment)
Trial: 19440326
Drug: Deferred ART
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Deferred ART (initiated after acute OI treatment is completed)
Trial: 16477653
Drug: Vt =
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vt = 5 ml/kg
Trial: 16477653
Drug: Vt =
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vt = 3 ml/kg
Trial: 11800144
Drug: 30mg acitretin
RxNorm normalized name: Acitretin
DrugBank: Acitretin (DB00459)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 30mg acitretin daily
Trial: 9483596
Drug: suxamethonium 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: suxamethonium 1.0 mg.kg‐1